
Contact us
About company
Angstrom Pharmaceuticals develops new class of drugs targeting CD44 for the treatment of metastatic diseases and hematological malignancies.
US
Unknown
Unknown
Not verified company

Angstrom Pharmaceuticals develops new class of drugs targeting CD44 for the treatment of metastatic diseases and hematological malignancies.